| Nuclear factor-kappa B and its role in inflammatory lung disease KS Alharbi, NK Fuloria, S Fuloria, SB Rahman, WH Al-Malki, MAJ Shaikh, ... Chemico-biological interactions 345, 109568, 2021 | 193 | 2021 |
| Functionalized mesoporous silica nanoparticles in anticancer therapeutics A Barkat, S Beg, SK Panda, KS Alharbi, M Rahman, FJ Ahmed Seminars in cancer biology 69, 365-375, 2021 | 89 | 2021 |
| Nanomedicine in treatment of breast cancer–A challenge to conventional therapy M Afzal, KS Alharbi, NK Alruwaili, FA Al-Abassi, AAL Al-Malki, I Kazmi, ... Seminars in cancer biology 69, 279-292, 2021 | 81 | 2021 |
| A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer V Subramaniyan, S Fuloria, G Gupta, DH Kumar, M Sekar, KV Sathasivam, ... Chemico-biological interactions 351, 109735, 2022 | 66 | 2022 |
| Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma M Rahman, SA Al-Ghamdi, KS Alharbi, S Beg, K Sharma, F Anwar, ... Drug Delivery 26 (1), 782-793, 2019 | 65 | 2019 |
| Sodium alginate based drug delivery in management of breast cancer MAJ Shaikh, KS Alharbi, WH Almalki, SS Imam, M Albratty, AM Meraya, ... Carbohydrate polymers 292, 119689, 2022 | 63 | 2022 |
| Polysaccharide-based nanomedicines targeting lung cancer AA Bhat, G Gupta, KS Alharbi, O Afzal, ASA Altamimi, WH Almalki, I Kazmi, ... Pharmaceutics 14 (12), 2788, 2022 | 51 | 2022 |
| BBD-based development of itraconazole loaded nanostructured lipid carrier for topical delivery: in vitro evaluation and antimicrobial assessment Ameeduzzafar, M Qumber, NK Alruwaili, SNA Bukhari, KS Alharbi, ... Journal of pharmaceutical innovation 16, 85-98, 2021 | 49 | 2021 |
| Comparative effectiveness of EDTA and citric acid assisted phytoremediation of Ni contaminated soil by using canola (Brassica napus) H Nawaz, A Ali, MH Saleem, A Ameer, A Hafeez, K Alharbi, A Ezzat, ... Brazilian Journal of Biology 82, e261785, 2022 | 47 | 2022 |
| Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and … Ameeduzzafar, NK Alruwaili, SS Imam, NH Alotaibi, NA Alhakamy, ... AAPS PharmSciTech 21, 1-16, 2020 | 47 | 2020 |
| Stimulus responsive ocular gentamycin-ferrying chitosan nanoparticles hydrogel: formulation optimization, ocular safety and antibacterial assessment NK Alruwaili, A Zafar, SS Imam, KS Alharbi, NH Alotaibi, S Alshehri, ... International Journal of Nanomedicine, 4717-4737, 2020 | 45 | 2020 |
| Bioactive Apigenin loaded oral nano bilosomes: Formulation optimization to preclinical assessment A Zafar, NK Alruwaili, SS Imam, NH Alotaibi, KS Alharbi, M Afzal, R Ali, ... Saudi Pharmaceutical Journal 29 (3), 269-279, 2021 | 41 | 2021 |
| Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems S Zafar, S Beg, SK Panda, M Rahman, KS Alharbi, GK Jain, FJ Ahmad Seminars in cancer biology 69, 249-267, 2021 | 39 | 2021 |
| Development of solid lipid nanoparticle as carrier of pioglitazone for amplification of oral efficacy: formulation design optimization, in-vitro characterization and in-vivo … S Shaveta, J Singh, M Afzal, R Kaur, SS Imam, NK Alruwaili, KS Alharbi, ... Journal of Drug Delivery Science and Technology 57, 101674, 2020 | 39 | 2020 |
| Gene therapy approach with an emphasis on growth factors: theoretical and clinical outcomes in neurodegenerative diseases DGT Parambi, KS Alharbi, R Kumar, S Harilal, GES Batiha, ... Molecular Neurobiology, 1-43, 2022 | 38 | 2022 |
| Design, synthesis and biological evaluation of new HDAC1 and HDAC2 inhibitors endowed with ligustrazine as a novel cap moiety MM Al-Sanea, L Gotina, MFA Mohamed, D Grace Thomas Parambi, ... Drug design, development and therapy, 497-508, 2020 | 38 | 2020 |
| Novel 1, 2, 4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity HAM Gomaa, HAM El-Sherief, S Hussein, AM Gouda, OIA Salem, ... Bioorganic chemistry 105, 104369, 2020 | 37 | 2020 |
| Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer’s disease M Handa, S Tiwari, AK Yadav, WH Almalki, S Alghamdi, KS Alharbi, ... Drug Discovery Today 26 (12), 2881-2888, 2021 | 36 | 2021 |
| Exploring satisfaction level among outpatients regarding pharmacy facilities and services in the Kingdom of Saudi Arabia; a large regional analysis NH Alotaibi, AI Alzarea, AM Alotaibi, YH Khan, TH Mallhi, KS Alharbi, ... PloS one 16 (4), e0247912, 2021 | 35 | 2021 |
| Role of Medicinal plant‐derived Nutraceuticals as a potential target for the treatment of breast cancer KS Alharbi, WH Almalki, HA Makeen, M Albratty, AM Meraya, R Nagraik, ... Journal of Food Biochemistry 46 (12), e14387, 2022 | 33 | 2022 |
Imran KazmiProfessor在 kau.edu.sa 的电子邮件经过验证
